CN102030762A - 一种头孢丙烯的制备方法 - Google Patents
一种头孢丙烯的制备方法 Download PDFInfo
- Publication number
- CN102030762A CN102030762A CN 201010568994 CN201010568994A CN102030762A CN 102030762 A CN102030762 A CN 102030762A CN 201010568994 CN201010568994 CN 201010568994 CN 201010568994 A CN201010568994 A CN 201010568994A CN 102030762 A CN102030762 A CN 102030762A
- Authority
- CN
- China
- Prior art keywords
- reaction
- add
- organic phase
- prozef
- adds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 36
- WDLWHQDACQUCJR-ZAMMOSSLSA-N (6r,7r)-7-[[(2r)-2-azaniumyl-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(e)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)/C=C/C)C(O)=O)=CC=C(O)C=C1 WDLWHQDACQUCJR-ZAMMOSSLSA-N 0.000 title abstract description 6
- 229960002580 cefprozil Drugs 0.000 title abstract description 6
- 238000006243 chemical reaction Methods 0.000 claims abstract description 140
- KFCMZNUGNLCSJQ-NFBKMPQASA-N (4-methoxyphenyl)methyl (6r,7r)-3-(chloromethyl)-8-oxo-7-[(2-phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound C1=CC(OC)=CC=C1COC(=O)C1=C(CCl)CS[C@H]2N1C(=O)[C@H]2NC(=O)CC1=CC=CC=C1 KFCMZNUGNLCSJQ-NFBKMPQASA-N 0.000 claims abstract description 20
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 239000012074 organic phase Substances 0.000 claims description 60
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims description 57
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 57
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 54
- 238000003756 stirring Methods 0.000 claims description 48
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 40
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 39
- 229940059720 apra Drugs 0.000 claims description 39
- 238000005406 washing Methods 0.000 claims description 37
- 238000001035 drying Methods 0.000 claims description 36
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 33
- 238000001914 filtration Methods 0.000 claims description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 229930182555 Penicillin Natural products 0.000 claims description 27
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 27
- 229940049954 penicillin Drugs 0.000 claims description 27
- 102000004190 Enzymes Human genes 0.000 claims description 26
- 108090000790 Enzymes Proteins 0.000 claims description 26
- 230000001105 regulatory effect Effects 0.000 claims description 26
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 24
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 claims description 18
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 18
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 18
- 239000013078 crystal Substances 0.000 claims description 18
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 16
- RLSSMJSEOOYNOY-UHFFFAOYSA-N m-cresol Chemical compound CC1=CC=CC(O)=C1 RLSSMJSEOOYNOY-UHFFFAOYSA-N 0.000 claims description 16
- 150000002148 esters Chemical class 0.000 claims description 15
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- WNYFTWLTSLCQLO-UHFFFAOYSA-N [As].N1=CC=CC=C1 Chemical compound [As].N1=CC=CC=C1 WNYFTWLTSLCQLO-UHFFFAOYSA-N 0.000 claims description 9
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 9
- 238000002425 crystallisation Methods 0.000 claims description 9
- 230000008025 crystallization Effects 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 9
- 239000012452 mother liquor Substances 0.000 claims description 9
- 229910052757 nitrogen Inorganic materials 0.000 claims description 9
- 239000003960 organic solvent Substances 0.000 claims description 9
- 239000002253 acid Substances 0.000 claims description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 claims description 6
- 229960001701 chloroform Drugs 0.000 claims description 6
- 230000000911 decarboxylating effect Effects 0.000 claims description 6
- 238000000605 extraction Methods 0.000 claims description 6
- 238000000926 separation method Methods 0.000 claims description 6
- 229930186147 Cephalosporin Natural products 0.000 claims description 5
- 229940124587 cephalosporin Drugs 0.000 claims description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- -1 methoxybenzyl ester Chemical class 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 239000012071 phase Substances 0.000 claims description 3
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 claims description 3
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 2
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 claims description 2
- 239000003513 alkali Substances 0.000 claims description 2
- 229910021529 ammonia Inorganic materials 0.000 claims description 2
- 238000006911 enzymatic reaction Methods 0.000 claims description 2
- 229910052740 iodine Inorganic materials 0.000 claims description 2
- 239000011630 iodine Substances 0.000 claims description 2
- 125000003717 m-cresyl group Chemical group [H]C1=C([H])C(O*)=C([H])C(=C1[H])C([H])([H])[H] 0.000 claims description 2
- 239000012046 mixed solvent Substances 0.000 claims description 2
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 claims description 2
- 150000007530 organic bases Chemical class 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 13
- 230000008901 benefit Effects 0.000 abstract description 2
- 238000009776 industrial production Methods 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- 238000003541 multi-stage reaction Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 18
- 238000012544 monitoring process Methods 0.000 description 12
- 239000007791 liquid phase Substances 0.000 description 8
- DYLIWHYUXAJDOJ-OWOJBTEDSA-N (e)-4-(6-aminopurin-9-yl)but-2-en-1-ol Chemical compound NC1=NC=NC2=C1N=CN2C\C=C\CO DYLIWHYUXAJDOJ-OWOJBTEDSA-N 0.000 description 5
- 238000010189 synthetic method Methods 0.000 description 5
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- HSHGZXNAXBPPDL-HZGVNTEJSA-N 7beta-aminocephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@@H]12 HSHGZXNAXBPPDL-HZGVNTEJSA-N 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- 0 C[C@@]([C@](C)N1C(C(*)=O)=C(CS)CCl)C1=O Chemical compound C[C@@]([C@](C)N1C(C(*)=O)=C(CS)CCl)C1=O 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- 150000001780 cephalosporins Chemical class 0.000 description 3
- 241000606768 Haemophilus influenzae Species 0.000 description 2
- LSBDFXRDZJMBSC-UHFFFAOYSA-N NC(Cc1ccccc1)=O Chemical compound NC(Cc1ccccc1)=O LSBDFXRDZJMBSC-UHFFFAOYSA-N 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 125000004368 propenyl group Chemical group C(=CC)* 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- ALYUMNAHLSSTOU-CIRGZYLNSA-N (6r,7r)-7-[[(2r)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-8-oxo-3-[(e)-prop-1-enyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrate Chemical compound O.C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)/C=C/C)C(O)=O)=CC=C(O)C=C1 ALYUMNAHLSSTOU-CIRGZYLNSA-N 0.000 description 1
- GQKJMIGSASLMID-FWNCORBQSA-N C/C=C/C(CS[C@@H]1[C@@H]2N)=C(C(C=O)=O)N1C2=O Chemical compound C/C=C/C(CS[C@@H]1[C@@H]2N)=C(C(C=O)=O)N1C2=O GQKJMIGSASLMID-FWNCORBQSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 241000193985 Streptococcus agalactiae Species 0.000 description 1
- 241000193998 Streptococcus pneumoniae Species 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- BCMPVBNNIHFSLU-UFHPHHKVSA-N benzhydryl (6r,7r)-3-(chloromethyl)-8-oxo-7-[(2-phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate Chemical compound N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)CCl)C(=O)OC(C=1C=CC=CC=1)C=1C=CC=CC=1)C(=O)CC1=CC=CC=C1 BCMPVBNNIHFSLU-UFHPHHKVSA-N 0.000 description 1
- 229960003719 cefdinir Drugs 0.000 description 1
- RTXOFQZKPXMALH-GHXIOONMSA-N cefdinir Chemical compound S1C(N)=NC(C(=N\O)\C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 RTXOFQZKPXMALH-GHXIOONMSA-N 0.000 description 1
- 229960002129 cefixime Drugs 0.000 description 1
- OKBVVJOGVLARMR-QSWIMTSFSA-N cefixime Chemical compound S1C(N)=NC(C(=N\OCC(O)=O)\C(=O)N[C@@H]2C(N3C(=C(C=C)CS[C@@H]32)C(O)=O)=O)=C1 OKBVVJOGVLARMR-QSWIMTSFSA-N 0.000 description 1
- 229960000484 ceftazidime Drugs 0.000 description 1
- NMVPEQXCMGEDNH-TZVUEUGBSA-N ceftazidime pentahydrate Chemical compound O.O.O.O.O.S([C@@H]1[C@@H](C(N1C=1C([O-])=O)=O)NC(=O)\C(=N/OC(C)(C)C(O)=O)C=2N=C(N)SC=2)CC=1C[N+]1=CC=CC=C1 NMVPEQXCMGEDNH-TZVUEUGBSA-N 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000010511 deprotection reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- BDAGIHXWWSANSR-UHFFFAOYSA-N formic acid Substances OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 1
- 229940047650 haemophilus influenzae Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000004682 monohydrates Chemical class 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 229940031000 streptococcus pneumoniae Drugs 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Landscapes
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Cephalosporin Compounds (AREA)
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010568994 CN102030762B (zh) | 2010-12-02 | 2010-12-02 | 一种头孢丙烯水合物的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 201010568994 CN102030762B (zh) | 2010-12-02 | 2010-12-02 | 一种头孢丙烯水合物的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102030762A true CN102030762A (zh) | 2011-04-27 |
CN102030762B CN102030762B (zh) | 2012-12-26 |
Family
ID=43884270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 201010568994 Expired - Fee Related CN102030762B (zh) | 2010-12-02 | 2010-12-02 | 一种头孢丙烯水合物的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102030762B (zh) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102911187A (zh) * | 2012-10-11 | 2013-02-06 | 南通康鑫药业有限公司 | 一种头孢丙烯的回收方法 |
CN103524533A (zh) * | 2013-10-10 | 2014-01-22 | 珠海金鸿药业股份有限公司 | 一种头孢丙烯化合物、其分散片、干混悬剂及制备方法 |
CN105085294A (zh) * | 2015-09-16 | 2015-11-25 | 山东鲁抗立科药业有限公司 | 一种从酶法合成头孢丙烯生产废液中回收d-对羟基苯甘氨酸的方法 |
CN106083893A (zh) * | 2016-07-04 | 2016-11-09 | 湖北凌晟药业有限公司 | 7‑苯乙酰氨基‑3‑丙烯基‑4‑头孢烯酸对甲氧基苄酯的制备方法 |
CN108440567A (zh) * | 2018-04-03 | 2018-08-24 | 天方药业有限公司 | 一种头孢丙烯的合成新方法 |
CN108530467A (zh) * | 2018-05-02 | 2018-09-14 | 天方药业有限公司 | 一种头孢丙烯的精制方法及其产品 |
CN109232608A (zh) * | 2018-11-14 | 2019-01-18 | 湖北凌晟药业有限公司 | 一种头孢丙烯的制备方法 |
CN112322688A (zh) * | 2020-11-06 | 2021-02-05 | 广药白云山化学制药(珠海)有限公司 | 一种从头孢丙烯生产废液中回收7-apra的方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998004732A1 (en) * | 1996-07-26 | 1998-02-05 | Bristol-Myers Squibb Company | SYNTHESIS OF β-LACTAM ANTIBACTERIALS USING SOLUBLE SIDE CHAIN ESTERS AND ENZYME ACYLASE |
CN101024649A (zh) * | 2006-02-23 | 2007-08-29 | 上海医药科技发展有限公司 | 口服非酯型抗生素头孢丙烯的制备方法 |
-
2010
- 2010-12-02 CN CN 201010568994 patent/CN102030762B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998004732A1 (en) * | 1996-07-26 | 1998-02-05 | Bristol-Myers Squibb Company | SYNTHESIS OF β-LACTAM ANTIBACTERIALS USING SOLUBLE SIDE CHAIN ESTERS AND ENZYME ACYLASE |
CN101024649A (zh) * | 2006-02-23 | 2007-08-29 | 上海医药科技发展有限公司 | 口服非酯型抗生素头孢丙烯的制备方法 |
Non-Patent Citations (1)
Title |
---|
《中国抗生素杂志》 20070131 冯胜昔 反式头孢丙烯的酶法合成及其体外抗菌活性 第23-24页 1、5-10 第32卷, 第1期 * |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102911187A (zh) * | 2012-10-11 | 2013-02-06 | 南通康鑫药业有限公司 | 一种头孢丙烯的回收方法 |
CN102911187B (zh) * | 2012-10-11 | 2015-03-11 | 南通康鑫药业有限公司 | 一种头孢丙烯的回收方法 |
CN103524533A (zh) * | 2013-10-10 | 2014-01-22 | 珠海金鸿药业股份有限公司 | 一种头孢丙烯化合物、其分散片、干混悬剂及制备方法 |
CN103524533B (zh) * | 2013-10-10 | 2016-01-27 | 珠海金鸿药业股份有限公司 | 一种头孢丙烯化合物、其分散片、干混悬剂及制备方法 |
CN105085294A (zh) * | 2015-09-16 | 2015-11-25 | 山东鲁抗立科药业有限公司 | 一种从酶法合成头孢丙烯生产废液中回收d-对羟基苯甘氨酸的方法 |
CN106083893B (zh) * | 2016-07-04 | 2018-06-29 | 湖北凌晟药业有限公司 | 7-苯乙酰氨基-3-丙烯基-4-头孢烯酸对甲氧基苄酯的制备方法 |
CN106083893A (zh) * | 2016-07-04 | 2016-11-09 | 湖北凌晟药业有限公司 | 7‑苯乙酰氨基‑3‑丙烯基‑4‑头孢烯酸对甲氧基苄酯的制备方法 |
CN108440567A (zh) * | 2018-04-03 | 2018-08-24 | 天方药业有限公司 | 一种头孢丙烯的合成新方法 |
CN108530467A (zh) * | 2018-05-02 | 2018-09-14 | 天方药业有限公司 | 一种头孢丙烯的精制方法及其产品 |
CN109232608A (zh) * | 2018-11-14 | 2019-01-18 | 湖北凌晟药业有限公司 | 一种头孢丙烯的制备方法 |
CN109232608B (zh) * | 2018-11-14 | 2020-04-28 | 湖北凌晟药业有限公司 | 一种头孢丙烯的制备方法 |
CN112322688A (zh) * | 2020-11-06 | 2021-02-05 | 广药白云山化学制药(珠海)有限公司 | 一种从头孢丙烯生产废液中回收7-apra的方法 |
CN112322688B (zh) * | 2020-11-06 | 2022-10-25 | 广药白云山化学制药(珠海)有限公司 | 一种从酶催化合成头孢丙烯生产废液中回收7-apra的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102030762B (zh) | 2012-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102030762B (zh) | 一种头孢丙烯水合物的制备方法 | |
CN101045733B (zh) | 一种头孢替安盐酸盐制备方法 | |
CN100500671C (zh) | 一种抗菌素硫酸头孢匹罗的合成方法 | |
CN101671349B (zh) | 一种新路线的头孢呋辛钠化合物 | |
CN102659817B (zh) | 一种头孢地尼的制备方法 | |
CN101220040A (zh) | 一种头孢克肟的制备及精制方法 | |
CN103030651A (zh) | 头孢他啶盐酸盐制备方法 | |
CN102617601A (zh) | 一种头孢地尼的制备方法 | |
CN107266473B (zh) | 一种头孢他啶的合成方法 | |
CN103467496A (zh) | 7-[(噻唑基羟基亚氨基)乙酰氨基]-3-甲基头孢烷酸的制备方法及另一用途 | |
CN101337970B (zh) | 一种抗菌素硫酸头孢匹罗的合成方法 | |
CN101798312B (zh) | 一种制备头孢丙烯化合物的方法 | |
CN101654458A (zh) | 一种盐酸头孢噻呋的制备方法 | |
CN103992337A (zh) | 一种便捷的制备阿扑西林钠的方法 | |
CN104277053A (zh) | 一种高纯度头孢地嗪及其中间体头孢地嗪酸的制备方法 | |
CN100480251C (zh) | 化合物头孢匹胺钠的合成方法 | |
CN108017658B (zh) | 一种头孢丙烯的合成方法 | |
CN105294734B (zh) | 一种制备头孢尼西二苄基乙二胺盐的方法 | |
CN102443013A (zh) | 一种头孢丙烯二甲基甲酰胺溶剂化物的制备方法 | |
CN105063158A (zh) | 一种头孢丙烯的合成方法 | |
CN101550152B (zh) | 一种头孢克洛化合物及其制法 | |
CN102532168A (zh) | 头孢哌酮酸的合成方法 | |
CN108299470B (zh) | 一种头孢特仑新戊酯的制备方法 | |
CN102267953A (zh) | 合成头孢拉定或Cefroxadine的中间体化合物及其制备方法和应用 | |
CN102898443B (zh) | 高收率超净高纯化头孢地嗪钠的精制方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
C56 | Change in the name or address of the patentee |
Owner name: SINOPHARM GROUP ZHIJUN (SUZHOU) PHARMACEUTICAL CO. Free format text: FORMER NAME: SUZHOU ZHIJUN WANQING PHARMACEUTICAL CO., LTD. |
|
CP01 | Change in the name or title of a patent holder |
Address after: 215415 Taicang Regal Economic Development Zone, Jiangsu Patentee after: SINOPHARM ZHIJUN (SUZHOU) PHARMACEUTICAL CO.,LTD. Address before: 215415 Taicang Regal Economic Development Zone, Jiangsu Patentee before: SUZHOU ZHIJUN WANQING PHARMACEUTICAL Co.,Ltd. |
|
PP01 | Preservation of patent right | ||
PP01 | Preservation of patent right |
Effective date of registration: 20200410 Granted publication date: 20121226 |
|
PD01 | Discharge of preservation of patent | ||
PD01 | Discharge of preservation of patent |
Date of cancellation: 20230410 Granted publication date: 20121226 |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20121226 |